  
    18th Annual
T-Cell Lymphoma Forum

February 4-6, 2027

Loews Coronado Bay Resort
San Diego

Conference rate $279
Reservations must be made by January 6, 2027

Book Hotel

Call for
Scientific
Abstracts

Deadline extended to November 15

Learn more

Call for
Fellows’ Forum
Abstracts

Deadline extended to November 15

Learn more

The T-Cell Lymphoma Forum is the foremost U.S. meeting dedicated to T-cell lymphomas and is recognized internationally for its scientific excellence. Designed to foster meaningful collaboration, the 18th Annual T-Cell Lymphoma Forum will bring together established leaders and emerging investigators to promote scientific exchange, mentorship, and innovation across the field.

This comprehensive two-and-a-half-day program provides a unique overview of the latest advances in T-cell lymphoma, spanning cutting-edge research, translational science, and evolving treatment strategies. Attendees include leading clinicians, researchers, and industry experts, creating a dynamic environment for interdisciplinary discussion and discovery.

This activity is not accredited for Continuing Education.

For more information:

uvace@uvahealth.org

Topics include:

Pathology and Molecular Pathogenesis
New Therapeutic Interventions
Deep Dive: The Role of Viruses in T/NK-cell Malignancies
CTCL Catch-Up
The Role of Adoptive Cellular and Immunotherapies for Peripheral T-Cell Lymphoma (PTCL)
Collaborations with Industry

Target audience:

This course has been designed for all clinicians and scientists with an interest in T-cell Lymphoma, including physicians and other healthcare professionals practicing in hematology, oncology, and related fields.